United States · FDA National Drug Code directory
LIDOCAINE HCI AND EPINEPHRINE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 51662-1506_12049309-a20f-8104-e063-6294a90a8466
- Product NDC
- 51662-1506
- Form
- INJECTION, SOLUTION
- Composition / generic term
- LIDOCAINE HCI AND EPINEPHRINE
- Labeler
- HF Acquisition Co LLC, DBA HealthFirst
- Marketing category
- NDA
- Marketing start / end (source format)
- 20200311
- Source listing expiry
- 20261231
Source-listed ingredients
- LIDOCAINE HYDROCHLORIDE ANHYDROUS — 20 mg/mL
- EPINEPHRINE BITARTRATE — .01 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 20 mL in 1 VIAL, MULTI-DOSE (51662-1506-1) · 51662-1506-1
- 1 VIAL, MULTI-DOSE in 1 POUCH (51662-1506-2) / 20 mL in 1 VIAL, MULTI-DOSE · 51662-1506-2
- 25 POUCH in 1 CASE (51662-1506-3) / 1 VIAL, MULTI-DOSE in 1 POUCH / 20 mL in 1 VIAL, MULTI-DOSE · 51662-1506-3
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →